Cite

HARVARD Citation

    Bézay, N. et al. (2016). Safety, immunogenicity and dose response of VLA84, a new vaccine candidate against Clostridium difficile, in healthy volunteers. Vaccine. 34 (23), pp. 2585-2592. [Online]. 
  
Back to record